Cargando…
Chromomycin A(2) potently inhibits glucose-stimulated insulin secretion from pancreatic β cells
Modulators of insulin secretion could be used to treat diabetes and as tools to investigate β cell regulatory pathways in order to increase our understanding of pancreatic islet function. Toward this goal, we previously used an insulin-linked luciferase that is cosecreted with insulin in MIN6 β cell...
Autores principales: | Kalwat, Michael A., Hwang, In Hyun, Macho, Jocelyn, Grzemska, Magdalena G., Yang, Jonathan Z., McGlynn, Kathleen, MacMillan, John B., Cobb, Melanie H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279362/ https://www.ncbi.nlm.nih.gov/pubmed/30352794 http://dx.doi.org/10.1085/jgp.201812177 |
Ejemplares similares
-
Sucralose activates an ERK1/2–ribosomal protein S6 signaling axis
por: Guerra, Marcy L., et al.
Publicado: (2017) -
α(2)-Adrenergic Disruption of β Cell BDNF-TrkB Receptor Tyrosine Kinase Signaling
por: Kalwat, Michael A., et al.
Publicado: (2020) -
Chromomycin A2 Induces Autophagy in Melanoma Cells
por: Guimarães, Larissa Alves, et al.
Publicado: (2014) -
Targeting the Oncogenic TBX2 Transcription Factor With Chromomycins
por: Sahm, Bianca Del B., et al.
Publicado: (2020) -
Manipulation of two regulatory genes for efficient production of chromomycins in Streptomyces reseiscleroticus
por: Sun, Lei, et al.
Publicado: (2018)